Seimiya H, Sawada H, Muramatsu Y, Shimizu M, Ohko K, Yamane K, Tsuruo T
Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, 1-37-1 Kami-Ikebukuro, Toshima-ku, Tokyo 170-8455, Japan.
EMBO J. 2000 Jun 1;19(11):2652-61. doi: 10.1093/emboj/19.11.2652.
Maintenance of telomeres is implicated in chromosome stabilization and cell immortalization. Telomerase, which catalyzes de novo synthesis of telomeres, is activated in germ cells and most cancers. Telomerase activity is regulated by gene expression for its catalytic subunit, TERT, whereas several lines of evidence have suggested a post-translational regulation of telomerase activity. Here we identify the 14-3-3 signaling proteins as human TERT (hTERT)-binding partners. A dominant-negative 14-3-3 redistributed hTERT, which was normally predominant in the nucleus, into the cytoplasm. Consistent with this observation, hTERT-3A, a mutant that could not bind 14-3-3, was localized into the cytoplasm. Leptomycin B, an inhibitor of CRM1/exportin 1-mediated nuclear export, or disruption of a nuclear export signal (NES)-like motif located just upstream of the 14-3-3 binding site in hTERT impaired the cytoplasmic localization of hTERT. Compared with wild-type hTERT, hTERT-3A increased its association with CRM1. 14-3-3 binding was not required for telomerase activity either in vitro or in cell extracts. These observations suggest that 14-3-3 enhances nuclear localization of TERT by inhibiting the CRM1 binding to the TERT NES-like motif.
端粒的维持与染色体稳定和细胞永生化有关。端粒酶催化端粒的从头合成,在生殖细胞和大多数癌症中被激活。端粒酶活性受其催化亚基TERT基因表达的调控,而有几条证据表明存在端粒酶活性的翻译后调控。在这里,我们鉴定出14-3-3信号蛋白是人TERT(hTERT)的结合伴侣。一种显性负性14-3-3将通常在细胞核中占主导的hTERT重新分布到细胞质中。与这一观察结果一致,不能结合14-3-3的突变体hTERT-3A定位于细胞质中。CRM1/exportin 1介导的核输出抑制剂雷帕霉素B,或破坏hTERT中14-3-3结合位点上游类似核输出信号(NES)的基序,会损害hTERT的细胞质定位。与野生型hTERT相比,hTERT-3A增加了其与CRM1的结合。在体外或细胞提取物中,端粒酶活性都不需要14-3-3结合。这些观察结果表明,14-3-3通过抑制CRM1与TERT NES样基序的结合来增强TERT的核定位。